SCHEMBL3744406

SCHEMBL3744406

N[C@H](CS(=O)(=O)O)C(=O)O.[Cu]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.44
▸ SLC7A11 Q9UPY5 1/20 0.44
▸ PMP22 Q01453 2/20 0.43
▸ KYNU Q16719 2/20 0.43
▸ NOS2 P35228 1/20 0.43
▸ GCLC P48506 1/20 0.41
▸ SLC1A1 P43005 4/20 0.41
▸ SLC1A3 P43003 3/20 0.41
▸ SLC1A2 P43004 3/20 0.41
▸ GSR P00390 2/20 0.41
▸ GRIK1 P39086 2/20 0.41
▸ GRIK2 Q13002 2/20 0.41
▸ GRM1 Q13255 2/20 0.41
▸ GRM2 Q14416 2/20 0.41
▸ SLC7A5 Q01650 1/20 0.41
▸ GRM8 O00222 1/20 0.41
▸ GRM6 O15303 1/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180559 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL44031 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL30600100 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL1395227 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL44030 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL21518548 0.97 PTGS1 (0.46) PTGS1SLC7A11PMP22KYNUNOS2
Hydrochloric Acid SCHEMBL3192875 0.95 PTGS1 (0.44) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL16194529 0.95 PTGS1 (0.44) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL1067778 0.95 PTGS1 (0.44) PTGS1SLC7A11PMP22KYNUNOS2
SCHEMBL22720617 0.95 PTGS1 (0.44) PTGS1SLC7A11PMP22KYNUNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040105894-A1 Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions GUPTA SHYAM K (US) 2004-06-03 — — US claimed
US-20260101895-A1 FUNGICIDAL AGENT AND COMPOSITION INNOSPEC LTD (GB) 2026-04-16 — — US disclosed
EP-4598349-A1 FUNGICIDAL AGENT AND COMPOSITION Innospec Limited (GB) 2025-08-13 — — EP disclosed
US-11986597-B2 Nitric oxide generating systems for inhalation NOTA Laboratories, LLC (US) 2024-05-21 — — US disclosed
WO-2024074809-A1 FUNGICIDAL AGENT AND COMPOSITION INNOSPEC LIMITED (GB) 2024-04-11 — — WO disclosed
US-20210178106-A1 NITRIC OXIDE GENERATING SYSTEMS FOR INHALATION NOTA Laboratories, LLC 2021-06-17 — — US disclosed
US-7834210-B2 Hair loss prevention by natural amino acid and peptide complexes BIODERM RESEARCH (US) 2010-11-16 — — US disclosed
US-20090253668-A1 Hair Loss Prevention by Natural Amino Acid and Peptide Complexes BIODERM RESEARCH (US) 2009-10-08 — — US disclosed
US-7572933-B2 Skin and hair restoration by natural amino acid peptide complexes BIODERM RESEARCH (US) 2009-08-11 — — US disclosed
US-20080287536-A1 Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes BIODERM RESEARCH (US) 2008-11-20 — — US disclosed
US-7427690-B2 Multifunction “crown complexes” from amino acids and peptides for skin and hair restoration BIODERM RESEARCH (US) 2008-09-23 — — US disclosed
US-20070099886-A1 Multifunction \"Crown Complexes\" from Amino Acids and Peptides for Skin and Hair Restoration BIODERM RESEARCH (US) 2007-05-03 — — US disclosed
US-5576326-A Copper amino acidate diimine nitrate compounds and their methyl derivatives and a process for preparing them UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (UNAM) (MX) 1996-11-19 — — US disclosed
EP-0434445-A2 Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) 1991-06-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260101895-A1 FUNGICIDAL AGENT AND COMPOSITION SLC7A1, AOC1, AOC2 PTGS1 4750/4885SLC7A11 18/4885PMP22 1983/4885
US-20080287536-A1 Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes MMP17, MC1R, TYR PTGS1 436/4885SLC7A11 1227/4885PMP22 1501/4885
US-20090253668-A1 Hair Loss Prevention by Natural Amino Acid and Peptide Complexes MMP1, MMP17, MMP13 PTGS1 1192/4885SLC7A11 870/4885PMP22 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback